Mammalian defensins: structures and mechanism of antibiotic activity
暂无分享,去创建一个
Alessandro Tossi | Nikolinka Antcheva | H. Sahl | A. Tossi | U. Pag | Ulrike Pag | N. Antcheva | Hans‐Georg Sahl | Sonja Bonness | Sandra Wagner | S. Bonness | S. Wagner
[1] B. Neumeister,et al. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. , 2002, The Journal of infectious diseases.
[2] Robert E W Hancock,et al. Role of membranes in the activities of antimicrobial cationic peptides. , 2002, FEMS microbiology letters.
[3] J. Travers,et al. Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes 1 , 2003, The Journal of Immunology.
[4] T. Ganz,et al. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. , 2001, Blood.
[5] R. Hancock,et al. Mammalian host defense peptides , 2004 .
[6] N. Fujii,et al. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.
[7] Oscar P. Kuipers,et al. Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity* , 2001, The Journal of Biological Chemistry.
[8] D. Hoover,et al. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. , 2004, Annual review of immunology.
[9] Y. Shai,et al. Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.
[10] R. Hancock,et al. The role of cationic antimicrobial peptides in innate host defences. , 2000, Trends in microbiology.
[11] H. G. Boman,et al. Gene‐Encoded Peptide Antibiotics and the Concept of Innate Immunity: An Update Review , 1998, Scandinavian journal of immunology.
[12] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[13] R. Epand,et al. Relationship of membrane curvature to the formation of pores by magainin 2. , 1998, Biochemistry.
[14] H. Sticht,et al. Structure determination of human and murine β‐defensins reveals structural conservation in the absence of significant sequence similarity , 2001, Protein science : a publication of the Protein Society.
[15] H. Sahl,et al. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. , 1997, European journal of biochemistry.
[16] H. Sahl,et al. Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase , 1987, Journal of bacteriology.
[17] R I Lehrer,et al. Antimicrobial peptides of vertebrates. , 1998, Current opinion in immunology.
[18] R. Hancock,et al. Sublethal Concentrations of Pleurocidin-Derived Antimicrobial Peptides Inhibit Macromolecular Synthesis in Escherichia coli , 2002, Antimicrobial Agents and Chemotherapy.
[19] D. Hoover,et al. The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. , 2001, The Journal of biological chemistry.
[20] M. Boniotto,et al. Effects of Positively Selected Sequence Variations in Human and Macaca fascicularis β-Defensins 2 on Antimicrobial Activity , 2004, Antimicrobial Agents and Chemotherapy.
[21] Alessandro Tossi,et al. Amphipathic, α‐helical antimicrobial peptides , 2000 .
[22] S. Yonehara,et al. Translocation of Analogues of the Antimicrobial Peptides Magainin and Buforin across Human Cell Membranes* , 2003, The Journal of Biological Chemistry.
[23] J. Schröder,et al. Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.
[24] F C Kafatos,et al. Phylogenetic perspectives in innate immunity. , 1999, Science.
[25] H. Sahl,et al. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles , 1985, Antimicrobial Agents and Chemotherapy.
[26] C. B. Park,et al. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.
[27] A. Tossi,et al. Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity. , 1997, European journal of biochemistry.
[28] B. Christensson,et al. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator , 2001, Nature Medicine.
[29] A. Amoroso,et al. A study of host defence peptide β-defensin 3 in primates , 2003 .
[30] Andreas Peschel,et al. How do bacteria resist human antimicrobial peptides? , 2002, Trends in microbiology.
[31] William C. Parks,et al. Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria , 2000, Nature Immunology.
[32] D. Andreu,et al. Animal antimicrobial peptides: an overview. , 1998, Biopolymers.
[33] Robert Blumenthal,et al. The Structure of Human β-Defensin-2 Shows Evidence of Higher Order Oligomerization* , 2000, The Journal of Biological Chemistry.
[34] Alessandro Tossi,et al. Amphipathic α helical antimicrobial peptides. , 2001 .
[35] H. G. Boman. Innate immunity and the normal microflora , 2000, Immunological reviews.
[36] I. Ginsburg. Cationic peptides from leukocytes might kill bacteria by activating their autolytic enzymes causing bacteriolysis: why are publications proposing this concept never acknowledged? , 2001, Blood.
[37] Y. Shai,et al. Mode of action of linear amphipathic α-helical antimicrobial peptides , 1998 .
[38] O. Kuipers,et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. , 1999, Science.
[39] A. Tossi,et al. Molecular diversity in gene-encoded, cationic antimicrobial polypeptides. , 2002, Current pharmaceutical design.
[40] Huey W. Huang,et al. Action of antimicrobial peptides: two-state model. , 2000, Biochemistry.
[41] Y. Shai,et al. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. , 2004, The Journal of antimicrobial chemotherapy.
[42] A. Pardi,et al. Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. , 1995, Biochemistry.
[43] Oleg Chertov,et al. The Structure of Human β-Defensin-1 , 2001, The Journal of Biological Chemistry.
[44] L. Kwak,et al. Mammalian defensins in immunity: more than just microbicidal. , 2002, Trends in immunology.
[45] H. Sahl,et al. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. , 1998, Annual review of microbiology.
[46] Takaaki Ohtake,et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection , 2001, Nature.
[47] B. Neumeister,et al. MprF-Mediated Lysinylation of Phospholipids in Staphylococcus aureus Leads to Protection against Oxygen-Independent Neutrophil Killing , 2003, Infection and Immunity.
[48] H. Vogel,et al. The Solution Structures of the Human β-Defensins Lead to a Better Understanding of the Potent Bactericidal Activity of HBD3 against Staphylococcus aureus * , 2002, The Journal of Biological Chemistry.
[49] Ji Ming Wang,et al. β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .
[50] Michael Otto,et al. Staphylococcus aureus Resistance to Human Defensins and Evasion of Neutrophil Killing via the Novel Virulence Factor Mprf Is Based on Modification of Membrane Lipids with l-Lysine , 2001, The Journal of experimental medicine.
[51] H. Sahl,et al. Role of lipid‐bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics , 1998, Molecular microbiology.
[52] A. Driessen,et al. University of Groningen MECHANISTIC STUDIES OF LANTIBIOTIC-INDUCED PERMEABILIZATION OF PHOSPHOLIPID-VESICLES , 2017 .
[53] Göran Carlsson,et al. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study , 2002, The Lancet.
[54] Tomas Ganz,et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.